Literature DB >> 2145104

CD8+/DR+ T gamma cells inhibit the autologous mixed lymphocyte reaction.

M K Haynes1, J Miller, L Fuller.   

Abstract

The proliferative response of T cells during autologous mixed lymphocyte reactions (AMLR) was affected by depletion of IgG Fc receptor+ T lymphocytes (Tg). Removal of Tg cells resulted in enhanced proliferation, and EA-rosette isolated Tg cells, when added to AMLR cultures as irradiated third components, reduced the uptake of 3H-thymidine by 63-87% in a dose-dependent manner. Negative selection using an avidin-biotin affinity chromatography technique demonstrated that the suppression was mediated by DR+ Tg cells; the major proportion of which also expressed the CD8 antigen. By comparing AMLR supernatants collected from control (lacking Tg) and suppressed (containing Tg) cultures on days 2, 3, and 4, it was established that supernatants from suppressed cultures had significantly reduced levels of cytokine activity. These data indicate that the CD8+/DR+ Tg cells function as suppressor cells during an AMLR and reduce the proliferative response by inhibiting AMLR responder T cells from producing the cytokines necessary for in vitro growth.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2145104      PMCID: PMC1535165          DOI: 10.1111/j.1365-2249.1990.tb05423.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  24 in total

1.  Amplification of suppressor inducer pathway with monoclonal antibody, anti-2H4, identifying a novel epitope of the common leukocyte antigen/T200 antigen.

Authors:  T Takeuchi; C E Rudd; T F Tedder; S F Schlossman; C Morimoto
Journal:  Cell Immunol       Date:  1989-01       Impact factor: 4.868

2.  Immunoglobulin production in the autologous MLR: target of the suppressor-amplifier circuit.

Authors:  P A Gatenby; E G Engleman
Journal:  Clin Exp Immunol       Date:  1986-08       Impact factor: 4.330

3.  Activation of immune regulatory circuits among OKT4+ cells by autologous mixed lymphocyte reactions.

Authors:  H Kotani; S Takada; Y Ueda; Y Murakawa; N Suzuki; T Sakane
Journal:  Clin Exp Immunol       Date:  1984-05       Impact factor: 4.330

4.  Failure of autologous mixed lymphocyte reactions between T and non-T cells in patients with systemic lupus erythematosus.

Authors:  T Sakane; A D Steinberg; I Green
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

5.  Expression of OKT 8 antigen and Fc gamma receptors by suppressor cells mediating specific unresponsiveness between recipient and donor in renal-allograft-tolerant patients.

Authors:  B M Charpentier; M A Bach; P Lang; D Fries
Journal:  Transplantation       Date:  1983-11       Impact factor: 4.939

Review 6.  Immunoregulatory T cell subpopulations in man: dissection by monoclonal antibodies and Fc-receptors.

Authors:  R E Ballieux; C J Heijnen
Journal:  Immunol Rev       Date:  1983       Impact factor: 12.988

7.  Autologous mixed lymphocyte reaction in man. XIII. Characterization of the T-T autologous mixed lymphocyte reaction.

Authors:  S Gupta; G Chandy; M Thornton; M Goldberg
Journal:  J Clin Immunol       Date:  1985-05       Impact factor: 8.317

8.  Lymphocyte transformation induced by autologous cells. V. Generation of immunologic memory and specificity during the autologous mixed lymphocyte reaction.

Authors:  M E Weksler; R Kozak
Journal:  J Exp Med       Date:  1977-12-01       Impact factor: 14.307

9.  Autologous stimulation of human lymphocyte subpopulation.

Authors:  G Opelz; M Kiuchi; M Takasugi; P I Terasaki
Journal:  J Exp Med       Date:  1975-11-01       Impact factor: 14.307

10.  Production of a cytokine with interleukin 3-like properties and cytokine-dependent proliferation in human autologous mixed lymphocyte reaction.

Authors:  R Suzuki; S Suzuki; T Takahashi; K Kumagai
Journal:  J Exp Med       Date:  1986-11-01       Impact factor: 14.307

View more
  1 in total

1.  Transplant-associated autoimmune mechanisms in human hepatitis C virus infection.

Authors:  K Zucker; D Roth; R Cirocco; J Mathew; M Carreno; L Fuller; T Karatzas; Y Jin; G Burke; J Nery; M Webb; A Tzakis; V Esquenazi; J Miller
Journal:  J Clin Immunol       Date:  1996-01       Impact factor: 8.317

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.